XML 31 R18.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes
12 Months Ended
Dec. 31, 2021
Income Taxes  
Income Taxes

12.         Income Taxes

The Company’s components of loss before income tax (in thousands) were as follows:

Year Ended December 31, 

    

2021

    

2020

 

Domestic

$

(25,931)

$

(15,116)

Foreign

(3,186)

1,944

Loss before income tax

$

(29,117)

$

(13,172)

The Company’s components of income tax (expense) benefit (in thousands) were as follows:

Year Ended December 31, 

 

    

2021

    

2020

 

Current federal benefit

$

21

$

117

Current state expense

 

6

 

(131)

Deferred federal expense

 

(159)

 

(268)

Deferred state benefit

 

158

 

258

Income tax benefit (expense)

$

26

$

(24)

The income tax provision (in thousands) differs from the amount computed by applying the statutory federal income tax rate to loss before income tax as follows:

Year Ended December 31, 

    

2021

    

2020

 

Tax benefit computed at statutory rate of 21%

$

6,047

$

2,766

Change in valuation allowance

 

(6,632)

 

(2,152)

State income tax benefit, net of federal tax

 

130

 

100

Foreign loss (income)

 

706

 

(536)

Other

 

(225)

 

(202)

Income tax benefit (expense)

$

26

$

(24)

The Coronavirus Aid, Relief, and Economic Security Act (“The CARES Act”) was enacted on March 27, 2020 resulting in tax law changes that impacted the Company by accelerating the AMT credit owed to the Company and allowed for a temporary change in NOL taxable income limitations. For tax years beginning January 1, 2018 and those prior to 2021, an NOL deduction equal to 100% of taxable income is allowed. Tax years 2021 and forward will revert back to the 80% limitation established by the 2017 Tax Cuts and Jobs Act.

The Consolidated Appropriations Act, 2021 (“The ACT”) was enacted by Congress on December 27, 2020. The ACT did not have a material impact to the Company’s consolidated financial statements.

The principal components of the Company’s net deferred tax assets (liabilities) (in thousands) were as follows:

    

December 31, 

    

2021

    

2020

Deferred tax assets:

Federal tax net operating loss ("NOL") carryforward

$

30,649

$

26,754

Foreign tax NOL carryforward

 

6,947

 

6,244

State tax NOL carryforward

 

2,194

 

1,509

Other comprehensive income

235

273

Foreign deferred taxes

197

207

Right-of-use assets

 

125

 

124

Canadian start-up costs

90

104

Restricted stock and restricted stock unit awards

55

230

Other

 

48

 

51

Self-insurance

 

45

 

62

Workers’ compensation

 

11

 

44

Gross deferred tax assets

40,596

35,602

Less valuation allowances

 

(37,571)

 

(30,396)

Net deferred tax assets

3,025

5,206

Deferred tax liabilities:

Property and equipment

 

(3,045)

 

(5,225)

Net deferred tax liabilities

$

(20)

$

(19)

Domestic deferred tax liabilities

$

(20)

$

(19)

Foreign deferred tax liabilities

Net deferred tax liabilities

$

(20)

$

(19)

At December 31, 2021, the Company had a gross NOL for U.S. federal income tax purposes of approximately $145,949,000. This NOL will begin to expire in 2027. Losses incurred after the year ended December 31, 2017 have no expiration. The Company will carry forward the tax benefits related to federal net NOL of approximately $30,649,000. The Company also had state net NOLs that will affect state taxes of approximately $2,194,000 at December 31, 2021. State NOLs began to expire in 2015. The Company also had a Canadian gross NOL of $26,718,000 that will begin to expire in 2037.

In evaluating the possible sources of taxable income during 2021, the Company determined it is more likely than not that the remaining deferred tax assets will not be realizable. As a result, the Company recorded full valuation allowance against foreign deferred tax assets and its federal and state deferred tax assets with the exception of its trademark intangible.

At December 31, 2021 and 2020, the Company did not have any uncertain tax positions. The Company’s policy is to recognize interest and penalties related to an uncertain tax position in income tax expense.